SAHPRA Offices will be unavailable on 29 November 2024
Please note that SAHPRA Head Office, including Cape Town and Durban Regional Offices will be unavila...
29 November, 24Please note that SAHPRA Head Office, including Cape Town and Durban Regional Offices will be unavila...
29 November, 24SAHPRA offices will be closed for the festive season from 12:00 on Tuesday, 24 December 2024 and wil...
22 November, 24Pretoria, 21 November 2024 – The South African Health Products Regulatory Authority (SAHPRA) is awar...
21 November, 24Pretoria, 08 November 2024 –The South African Health Products Regulatory Authority (SAHPRA) is conce...
08 November, 24There have been several cases around the world in which Tranexamic acid has been administered intrat...
21 December, 23The South African Health Products Regulatory Authority (SAHPRA) would like to inform you of a signal...
19 October, 21In collaboration with the South African Health Products Regulatory Authority (SAHPRA), Roche Product...
10 November, 20SAHPRA alerts all healthcare professionals about the risk of serious heart problems, seizures, coma ...
01 November, 20This recall is initiated due to a limited number of packs found in retail Pharmacy, with mix-up of the sequence of hormone-containing and hormone-free tablets, wherein some packs had • 24 light orange hormone-free, and • 4 pink film-coated hormone tablets Instead of • 24 pink film-coated hormone tablets and • 4 light orange hormone-free tablets.
This recall follows a recent internal quality review which identified a deviation in the supplier as well as the Transfer of Applicant pending to Austell Pharmaceuticals.
This recall is initiated due to labels of products imported from the United States and Europe not complying with certain regulatory requirements for Complementary Medicines as expressed in the SAPHRA guidelines.